Proton therapy in the treatment of hepatocellular carcinoma.

active scanning hepatocellular carcinoma photon therapy proton therapy review

Journal

Frontiers in oncology
ISSN: 2234-943X
Titre abrégé: Front Oncol
Pays: Switzerland
ID NLM: 101568867

Informations de publication

Date de publication:
2022
Historique:
received: 01 06 2022
accepted: 13 07 2022
entrez: 25 8 2022
pubmed: 26 8 2022
medline: 26 8 2022
Statut: epublish

Résumé

Liver cancer represents one of the most common causes of death from cancer worldwide. Hepatocellular carcinoma (HCC) accounts for 90% of all primary liver cancers. Among local therapies, evidence regarding the use of radiation therapy is growing. Proton therapy currently represents the most advanced radiation therapy technique with unique physical properties which fit well with liver irradiation. Here, in this review, we aim to 1) illustrate the rationale for the use of proton therapy (PT) in the treatment of HCC, 2) discuss the technical challenges of advanced PT in this disease, 3) review the major clinical studies regarding the use of PT for HCC, and 4) analyze the potential developments and future directions of PT in this setting.

Identifiants

pubmed: 36003769
doi: 10.3389/fonc.2022.959552
pmc: PMC9393743
doi:

Types de publication

Journal Article Review

Langues

eng

Pagination

959552

Informations de copyright

Copyright © 2022 Dionisi, Scartoni, Fracchiolla, Giacomelli, Siniscalchi, Goanta, Cianchetti, Sanguineti and Brolese.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

N Engl J Med. 2008 Jul 24;359(4):378-90
pubmed: 18650514
Med Phys. 2012 Sep;39(9):5584-91
pubmed: 22957624
Med Phys. 2022 Apr;49(4):e50-e81
pubmed: 35066871
Clin Med (Lond). 2008 Dec;8(6):579-88
pubmed: 19149278
Front Oncol. 2019 Feb 26;9:113
pubmed: 30863723
Cancer. 2011 Jul 1;117(13):3053-9
pubmed: 21264826
Hepatology. 1999 Jan;29(1):62-7
pubmed: 9862851
J Clin Oncol. 2013 May 1;31(13):1631-9
pubmed: 23547075
Carcinogenesis. 2008 Jul;29(7):1299-305
pubmed: 18515282
World J Gastroenterol. 2020 Jan 28;26(4):393-403
pubmed: 32063688
Lancet. 2012 Mar 31;379(9822):1245-55
pubmed: 22353262
Phys Med Biol. 2012 Apr 7;57(7):1779-95
pubmed: 22407290
Int J Radiat Oncol Biol Phys. 2014 Nov 15;90(4):952-8
pubmed: 25223297
Semin Radiat Oncol. 2011 Oct;21(4):247-55
pubmed: 21939853
Int J Radiat Oncol Biol Phys. 2010 Mar 1;76(3 Suppl):S94-100
pubmed: 20171524
Int J Radiat Oncol Biol Phys. 2007 Nov 1;69(3):805-12
pubmed: 17524568
Z Med Phys. 2022 Feb;32(1):63-73
pubmed: 33131995
Radiother Oncol. 2016 Nov;121(2):281-287
pubmed: 27726957
Radiat Oncol. 2013 Oct 27;8:250
pubmed: 24160944
Int J Radiat Oncol Biol Phys. 2002 Jul 15;53(4):810-21
pubmed: 12095546
Hepatology. 2003 Feb;37(2):429-42
pubmed: 12540794
Radiat Oncol. 2020 Jun 30;15(1):159
pubmed: 32605627
J Clin Oncol. 2016 Feb 10;34(5):460-8
pubmed: 26668346
Tumori. 2021 Feb;107(1):71-79
pubmed: 32648818
J Hepatol. 2021 Mar;74(3):603-612
pubmed: 33031846
Radiother Oncol. 2022 Apr;169:77-85
pubmed: 35189152
Cancer. 2005 Aug 15;104(4):794-801
pubmed: 15981284
Int J Radiat Oncol Biol Phys. 2010 Feb 1;76(2):460-6
pubmed: 19427743
Int J Radiat Oncol Biol Phys. 2016 May 1;95(1):477-482
pubmed: 27084661
Cancers (Basel). 2019 Feb 15;11(2):
pubmed: 30781391
Radiother Oncol. 2015 Mar;114(3):289-95
pubmed: 25497556
N Engl J Med. 2020 May 14;382(20):1894-1905
pubmed: 32402160
Cancer. 2009 Dec 1;115(23):5499-506
pubmed: 19645024
Radiother Oncol. 2021 Jan;154:137-144
pubmed: 32976870
Radiother Oncol. 2019 Jul;136:86-97
pubmed: 31015134
Gastroenterology. 2016 Dec;151(6):1155-1163.e2
pubmed: 27575820
Strahlenther Onkol. 2006 Dec;182(12):713-20
pubmed: 17149578
Int J Radiat Oncol Biol Phys. 2019 Sep 1;105(1):64-72
pubmed: 30684667
Radiother Oncol. 2009 Aug;92(2):184-94
pubmed: 19042048
Am J Cancer Res. 2022 Apr 15;12(4):1606-1620
pubmed: 35530291
CA Cancer J Clin. 2018 Nov;68(6):394-424
pubmed: 30207593
Radiother Oncol. 2018 Jul;128(1):182-188
pubmed: 29459153
Med Phys. 2017 Feb;44(2):703-712
pubmed: 28133755
Surg Today. 2020 Apr;50(4):369-378
pubmed: 31602531
Phys Med. 2019 Jan;57:215-220
pubmed: 30661743
Radiat Oncol. 2020 Nov 4;15(1):255
pubmed: 33148296
Cureus. 2017 Sep 10;9(9):e1674
pubmed: 29152431
Z Med Phys. 2018 Apr;28(2):121-133
pubmed: 28843397
Med Dosim. 2008 Winter;33(4):259-67
pubmed: 18973852
J Appl Clin Med Phys. 2021 Mar;22(3):63-71
pubmed: 33595910
Radiother Oncol. 2019 Jul;136:185-189
pubmed: 31015123

Auteurs

Francesco Dionisi (F)

Department of Radiation Oncology, IRCCS Regina Elena National Cancer Institute, Rome, Italy.

Daniele Scartoni (D)

Proton Therapy Unit, Azienda Provinciale per i Servizi Sanitari, Trento, Italy.

Francesco Fracchiolla (F)

Proton Therapy Unit, Azienda Provinciale per i Servizi Sanitari, Trento, Italy.

Irene Giacomelli (I)

Proton Therapy Unit, Azienda Provinciale per i Servizi Sanitari, Trento, Italy.

Benedetta Siniscalchi (B)

Proton Therapy Unit, Azienda Provinciale per i Servizi Sanitari, Trento, Italy.

Lucia Goanta (L)

Department of Advanced Biomedical Sciences, University of Naples "Federico II", Napoli, Italy.

Marco Cianchetti (M)

Proton Therapy Unit, Azienda Provinciale per i Servizi Sanitari, Trento, Italy.

Giuseppe Sanguineti (G)

Department of Radiation Oncology, IRCCS Regina Elena National Cancer Institute, Rome, Italy.

Alberto Brolese (A)

General Surgery & Hepato-Pancreato-Biliary Unit, Azienda Provinciale per i Servizi Sanitari, Trento, Italy.

Classifications MeSH